Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 14Unknown 2Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 140Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Hematologic Neoplasms 69Myelodysplastic Syndromes 55Lymphoma 47Lymphoma, Non-Hodgkin 45Lymphoma, B-Cell, Marginal Zone 34Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34Lymphoma, Mantle-Cell 33Lymphoma, Follicular 33Burkitt Lymphoma 32Recurrence 28Lymphoma, Large B-Cell, Diffuse 28Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Hodgkin Disease 23Neoplasms 22Leukemia, Myelomonocytic, Chronic 22Multiple Myeloma 21Myeloproliferative Disorders 20Waldenstrom Macroglobulinemia 19Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myeloid, Chronic-Phase 17Congenital Abnormalities 16Primary Myelofibrosis 15Leukemia, Myeloid, Accelerated Phase 14Leukemia, Biphenotypic, Acute 14Mycosis Fungoides 13Lymphoma, T-Cell, Cutaneous 13

Interventions

Mannose-Binding Lectin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Fever × Other hematologic neoplasm × Clear all
NCT00886496 2012-06-20

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Enzon Pharmaceuticals, Inc.

Phase 1 Withdrawn
LymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fever, Infections, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neutropenia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Hot Flashes, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡